Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease

NCT01693081 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: VR040/Aspirair® inhaler
DRUG: placebo

Sponsor

South Glasgow University Hospitals NHS Trust

Collaborators

[object Object]